Published in New England Journal of Medicine · View the paper (DOI)
A monoclonal antibody, omalizumab, increased the tolerance threshold for multiple food allergens, allowing children to consume larger amounts without a reaction. The treatment showed significant benefits in reducing allergic reactions, particularly for peanut and egg, with potential protection against accidental exposure.
Coverage from 2 institutions
- Antibody reduces allergic reactions to multiple foods in NIH trial NIH/National Institute of Allergy and Infectious Diseases · Feb 25, 2024 · first to report
- Drug limits dangerous reactions to allergy-triggering foods, Stanford Medicine-led study of kids finds Stanford Medicine · Feb 25, 2024